Matches in SemOpenAlex for { <https://semopenalex.org/work/W3002019936> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3002019936 abstract "We sought to evaluate whether additional topical anesthetic, specifically proparacaine 0.5%, improved patient experience with intravitreal injections without hindering antisepsis.A prospective, randomized controlled trial was conducted including 36 eyes of 36 patients undergoing intravitreal injections. Patients were randomized to treatment with additional topical proparacaine 0.5% versus control after undergoing informed consent. All patients prior to intravitreal injection underwent conjunctival culture after one drop of topical proparacaine 0.5% was placed. Half of patients then received an additional drop of proparacaine and then underwent a second conjunctival culture. The other half of patients had a drop of povidone iodine and then a second conjunctival culture. Intravitreal injection followed conjunctival cultures. To evaluate their experience, patients were provided with a survey.In total, 36 patients were enrolled in the study. Three of 36 (8.3%) patients had positive conjunctival cultures after proparacaine eye drops alone. One of 17 (5.8%) patients had a positive conjunctival culture after a second drop of proparacaine. One of 19 (5.3%) patients had a positive culture after proparacaine and povidone iodine. By noninferiority analysis, proparacaine was inferior to povidone iodine (p = .28). Patient experience surveys did not differ between groups.Patient perception did not significantly differ whether or not additional proparacaine drops were used prior to intravitreal injection in a randomized controlled trial. While proparacaine has some antiseptic properties, these were found to be inferior to those of povidone iodine. Therefore, while povidone iodine is essential for antisepsis, additional proparacaine drops should not interfere with antisepsis." @default.
- W3002019936 created "2020-01-30" @default.
- W3002019936 creator A5007777709 @default.
- W3002019936 creator A5030225841 @default.
- W3002019936 creator A5060065858 @default.
- W3002019936 creator A5061449685 @default.
- W3002019936 creator A5082704917 @default.
- W3002019936 date "2020-01-27" @default.
- W3002019936 modified "2023-09-26" @default.
- W3002019936 title "Topical proparacaine eye drops to improve the experience of patients undergoing intravitreal injections: A randomized controlled trial" @default.
- W3002019936 cites W1188428739 @default.
- W3002019936 cites W1576190909 @default.
- W3002019936 cites W1825996464 @default.
- W3002019936 cites W2034328921 @default.
- W3002019936 cites W2055486097 @default.
- W3002019936 cites W2056188631 @default.
- W3002019936 cites W2083153191 @default.
- W3002019936 cites W2104460601 @default.
- W3002019936 cites W2330800912 @default.
- W3002019936 cites W2742297576 @default.
- W3002019936 cites W2774419965 @default.
- W3002019936 cites W2776075738 @default.
- W3002019936 cites W2797657366 @default.
- W3002019936 cites W2467936911 @default.
- W3002019936 doi "https://doi.org/10.1177/1120672120902026" @default.
- W3002019936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31983237" @default.
- W3002019936 hasPublicationYear "2020" @default.
- W3002019936 type Work @default.
- W3002019936 sameAs 3002019936 @default.
- W3002019936 citedByCount "0" @default.
- W3002019936 crossrefType "journal-article" @default.
- W3002019936 hasAuthorship W3002019936A5007777709 @default.
- W3002019936 hasAuthorship W3002019936A5030225841 @default.
- W3002019936 hasAuthorship W3002019936A5060065858 @default.
- W3002019936 hasAuthorship W3002019936A5061449685 @default.
- W3002019936 hasAuthorship W3002019936A5082704917 @default.
- W3002019936 hasConcept C118487528 @default.
- W3002019936 hasConcept C141071460 @default.
- W3002019936 hasConcept C168563851 @default.
- W3002019936 hasConcept C2777932084 @default.
- W3002019936 hasConcept C2778162923 @default.
- W3002019936 hasConcept C42219234 @default.
- W3002019936 hasConcept C71924100 @default.
- W3002019936 hasConceptScore W3002019936C118487528 @default.
- W3002019936 hasConceptScore W3002019936C141071460 @default.
- W3002019936 hasConceptScore W3002019936C168563851 @default.
- W3002019936 hasConceptScore W3002019936C2777932084 @default.
- W3002019936 hasConceptScore W3002019936C2778162923 @default.
- W3002019936 hasConceptScore W3002019936C42219234 @default.
- W3002019936 hasConceptScore W3002019936C71924100 @default.
- W3002019936 hasFunder F4320306811 @default.
- W3002019936 hasLocation W30020199361 @default.
- W3002019936 hasLocation W30020199362 @default.
- W3002019936 hasOpenAccess W3002019936 @default.
- W3002019936 hasPrimaryLocation W30020199361 @default.
- W3002019936 hasRelatedWork W11521242 @default.
- W3002019936 hasRelatedWork W14210925 @default.
- W3002019936 hasRelatedWork W15240424 @default.
- W3002019936 hasRelatedWork W18459858 @default.
- W3002019936 hasRelatedWork W20266326 @default.
- W3002019936 hasRelatedWork W20440739 @default.
- W3002019936 hasRelatedWork W20580420 @default.
- W3002019936 hasRelatedWork W20598362 @default.
- W3002019936 hasRelatedWork W4461107 @default.
- W3002019936 hasRelatedWork W8129469 @default.
- W3002019936 isParatext "false" @default.
- W3002019936 isRetracted "false" @default.
- W3002019936 magId "3002019936" @default.
- W3002019936 workType "article" @default.